Global Menopause Market Size & Outlook, 2022-2030
Global menopause market, 2018-2030 (US$M)
Related Markets
Global menopause market highlights
- The global menopause market generated a revenue of USD 16,128.6 million in 2022 and is expected to reach USD 24,352.4 million by 2030.
- The market is expected to grow at a CAGR (2023 - 2030) of 5.3% by 2030.
- In terms of segment, dietary supplements accounted for a revenue of USD 15,350.9 million in 2022.
- Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2022.
- Country-wise, Canada is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 16,128.6 million |
| Market revenue in 2030 | USD 24,352.4 million |
| Growth rate | 5.3% (CAGR from 2022 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | Dietary Supplements |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | OTC pharma products, Dietary Supplements |
Other key industry trends
- In terms of revenue, the North America accounted for 36.0% of the global menopause market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Canada is the fastest growing regional market and is projected to reach USD 784.8 million by 2030.
Dietary supplements was the largest segment with a revenue share of 95.18% in 2022. Horizon Databook has segmented the Global menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
By 2025, over 1 billion women globally are anticipated to reach menopause, which would make up approximately 12% of the global population. Vasomotor symptoms are experienced by almost 75% of women undergoing menopause. This can lead to an overall loss of productivity and quality of life, making treatment crucial.
This creates a wide population pool to be served by menopause products, such as dietary supplements and over-the-counter drugs that can help relieve symptoms including hot flashes, osteoporosis, night sweats, & vaginal atrophy. Furthermore, early treatment can reduce stress of high healthcare expenditure, as women facing vasomotor symptoms lead to an overall burden of USD 660 million globally.
In addition, productivity loss accounts for additional USD 150 million. Menopause also triggers other healthcare conditions in women, such as reduced musculoskeletal health and increased risk of cardiovascular diseases.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Menopause Market Scope
Menopause Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global menopause market size, by regions, 2018-2030 (US$M)
Top 10 countries: Menopause market size, 2022 (US$M)
Global menopause market share, by treatment, 2022 & 2030 (%, US$M)
Menopause market: Opportunity assessment by country
Global menopause market, by region, 2022 (US$M)
Related industry reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
